Weaam F. Hussien, et al. “Investigation of Methylglyoxal, Soluble Receptor for Advanced Glycation End-Products, and Malondialdehyde in Type 2 Diabetes Mellitus With and Without Cardiovascular Risk Factors”. Diyala Journal of Medicine, vol. 29, no. 1, Oct. 2025, pp. 99-110, doi:10.26505/djm.v29i1.1501.